Crossmark

Pretreatment patient-specific quality assurance prediction based on 1D complexity metrics and 3D planning dose: classification, gamma passing rates, and DVH metrics

Crossref DOI link: https://doi.org/10.1186/s13014-023-02376-4

Published Online: 2023-11-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Liyuan

Luo, Huanli

Li, Shi

Tan, Xia

Feng, Bin

Yang, Xin

Wang, Ying

Jin, Fu
Funding

Funding for this research was provided by:

Natural Science Foundation Project of Chongqing (cstc2021jcyjmsxmX0441)

Science-Health Joint Project of Chongqing (2022DBXM005)
License Information

Text and Data Mining valid from 2023-11-20

Version of Record valid from 2023-11-20
More Information

Article History

Received: 8 June 2023

Accepted: 6 November 2023

First Online: 20 November 2023

Declarations

:

: This retrospective study was reviewed and approved by the Institutional Review Board of Chongqing University Cancer hospital (CZLS2023164-A) and the requirement for individual informed consent was waived.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below